Deruxtecan
Deruxtecan is a drug-linker conjugate featuring a DXd payload connected via a maleimide-GGFG peptide linker. It is a key component in the synthesis of ADCs like DS-8201 and U3-1402, enabling targeted cytotoxicity research in both in vitro and in vivo cancer models.
Product Specifications
CAS Number
1599440-13-7
Product Name Alternative
Inhibitor, inhibit, Camptothecins, DrugLinkerConjugatesforADC, DrugLinker Conjugates for ADC, Deruxtecan, Drug-Linker Conjugates for ADC
Field of Research
Pharmacology & Drug Discovery
Purity
97.03% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:2 mg/mL (1.93 mM) ; DMSO:262 mg/mL (253.37 mM)
Smiles
CC[C@@]1 (O) C (=O) OCc2c1cc1-c3nc4cc (F) c (C) c5CC[C@H] (NC (=O) COCNC (=O) CNC (=O) [C@H] (Cc6ccccc6) NC (=O) CNC (=O) CNC (=O) CCCCCN6C (=O) C=CC6=O) c (c3Cn1c2=O) c45
Molecular Formula
C52H56FN9O13
Molecular Weight
1034.05
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BAC10555-01 50 mg
4-Methyl-2- (oxolan-3-yl) -1,3-thiazole-5-carboxylic acid
Sign In for Pricing
View Details BAC10555-02 0.5 g
4-Methyl-2- (oxolan-3-yl) -1,3-thiazole-5-carboxylic acid
Sign In for Pricing
View Details 
CXB27761-01 100 mg
1-{[4- (4-Fluorophenyl) -1,3-thiazol-2-yl]methyl}piperazine dihydrochloride
Sign In for Pricing
View Details